The British Horseracing Authority has announced that it has adopted five new Detection Times for Romifidine, Salbutamol, Firocoxib, Butorphanol and the Romifidine/butorphanol combination.
These Detection Times are harmonised across the member countries of the European Horseracing Scientific Liaison Committee (EHSLC). The EHSLC has been investigating the detection times of commonly-used medications, in response to the need for more information on the time taken for drugs to be eliminated.
In addition, the BHA detection Time for Detomidine/Butorphanol has been harmonised with the Detection Time across Europe and raised from 48 to 72 hours. Most of these new Detection Times result from research performed at the Authority’s Centre for Racehorse Studies in Newmarket.
The “detection time” is the time at which the concentration of the drug (or its breakdown products) in the urine, is not detected using routine or standard methods, in all the horses in the study.
It is important to remember that “detection times” are not the same as “withdrawal times”. An additional safety margin should be added to allow for individual variation.
However, the figures will give some welcome guidance to veterinarians who have to advise on whether a horse is likely to test positive if treated in the days before a race.
Further information, including a downloadable sheet of all 31 BHA Detection Times, together with a full explanation of the limitations of the results, can be found on the Authority’s website
http://www.britishhorseracing.com/resources/equine-science-and-welfare/medication-control.asp
Information on withdrawal of supplements containing Devil’s Claw has also been added to the Notices section of the Authority’s Rules website, where further information the use of a number of medications can also be found.
http://rules.britishhorseracing.com/Orders-and-rules&staticID=126908&depth=2
No comments:
Post a Comment